60 related articles for article (PubMed ID: 37970615)
21. The Lymphatic System in Obesity, Insulin Resistance, and Cardiovascular Diseases.
Jiang X; Tian W; Nicolls MR; Rockson SG
Front Physiol; 2019; 10():1402. PubMed ID: 31798464
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of aged lymphatic vessels.
Shang T; Liang J; Kapron CM; Liu J
Aging (Albany NY); 2019 Aug; 11(16):6602-6613. PubMed ID: 31461408
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota regulates lacteal integrity by inducing VEGF-C in intestinal villus macrophages.
Suh SH; Choe K; Hong SP; Jeong SH; Mäkinen T; Kim KS; Alitalo K; Surh CD; Koh GY; Song JH
EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30783017
[TBL] [Abstract][Full Text] [Related]
24. Management of refractory cirrhotic ascites: challenges and solutions.
Fukui H; Kawaratani H; Kaji K; Takaya H; Yoshiji H
Hepat Med; 2018; 10():55-71. PubMed ID: 30013405
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical Analysis of Endothelial Cells in Vascular Transformation of Lymph Node Sinuses: Vascular or Lymphatic Differentiation?
Basha BM; Hsi ED
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):482-489. PubMed ID: 29629951
[TBL] [Abstract][Full Text] [Related]
26. Review article: the diagnostic approach and current management of chylous ascites.
Lizaola B; Bonder A; Trivedi HD; Tapper EB; Cardenas A
Aliment Pharmacol Ther; 2017 Nov; 46(9):816-824. PubMed ID: 28892178
[TBL] [Abstract][Full Text] [Related]
27. The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.
Tanaka M; Iwakiri Y
Cell Mol Gastroenterol Hepatol; 2016 Nov; 2(6):733-749. PubMed ID: 28105461
[TBL] [Abstract][Full Text] [Related]
28. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature.
Tsauo J; Shin JH; Han K; Yoon HK; Ko GY; Ko HK; Gwon DI
J Vasc Interv Radiol; 2016 Jan; 27(1):112-6. PubMed ID: 26723922
[TBL] [Abstract][Full Text] [Related]
29. Intestinal lymphangiectasia and reversible high liver stiffness.
Milazzo L; Peri AM; Lodi L; Gubertini G; Ridolfo AL; Antinori S
Hepatology; 2014 Aug; 60(2):759-61. PubMed ID: 24449480
[TBL] [Abstract][Full Text] [Related]
30. The lymphatic vascular system in liver diseases: its role in ascites formation.
Chung C; Iwakiri Y
Clin Mol Hepatol; 2013 Jun; 19(2):99-104. PubMed ID: 23837133
[TBL] [Abstract][Full Text] [Related]
31. Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats.
Ribera J; Pauta M; Melgar-Lesmes P; Tugues S; Fernández-Varo G; Held KF; Soria G; Tudela R; Planas AM; Fernández-Hernando C; Arroyo V; Jiménez W; Morales-Ruiz M
Gut; 2013 Jan; 62(1):138-45. PubMed ID: 22267600
[TBL] [Abstract][Full Text] [Related]
32. Atraumatic chylous ascites: systematic review on symptoms and causes.
Steinemann DC; Dindo D; Clavien PA; Nocito A
J Am Coll Surg; 2011 May; 212(5):899-905.e1-4. PubMed ID: 21398159
[No Abstract] [Full Text] [Related]
33. Intestinal lymphangiectasia in adults.
Freeman HJ; Nimmo M
World J Gastrointest Oncol; 2011 Feb; 3(2):19-23. PubMed ID: 21364842
[TBL] [Abstract][Full Text] [Related]
34. The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.
Aller MA; Prieto I; Argudo S; de Vicente F; Santamaría L; de Miguel MP; Arias JL; Arias J
Int J Inflam; 2010 Oct; 2010():148689. PubMed ID: 21152120
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver--re-evaluations of microlymphatic abnormalities.
Yokomori H; Oda M; Kaneko F; Kawachi S; Tanabe M; Yoshimura K; Kitagawa Y; Hibi T
BMC Gastroenterol; 2010 Nov; 10():131. PubMed ID: 21059220
[TBL] [Abstract][Full Text] [Related]
36. Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels.
Rehal S; Blanckaert P; Roizes S; von der Weid PY
Br J Pharmacol; 2009 Dec; 158(8):1961-70. PubMed ID: 19922540
[TBL] [Abstract][Full Text] [Related]
37. Modulation of lymphatic muscle contractility by the neuropeptide substance P.
Davis MJ; Lane MM; Davis AM; Durtschi D; Zawieja DC; Muthuchamy M; Gashev AA
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H587-97. PubMed ID: 18539752
[TBL] [Abstract][Full Text] [Related]
38. Portal hypertensive duodenopathy: clinical, endoscopic, and histopathologic profiles.
Barakat M; Mostafa M; Mahran Z; Soliman AG
Am J Gastroenterol; 2007 Dec; 102(12):2793-802. PubMed ID: 17900330
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of portal hypertensive duodenopathy in cirrhosis: clinical and haemodynamic features.
Menchén L; Ripoll C; Marín-Jiménez I; Colón A; Gómez-Camarero J; González-Asanza C; Menchén P; Cos E; Bañares R
Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):649-53. PubMed ID: 16702855
[TBL] [Abstract][Full Text] [Related]
40. The lymphatic system in body homeostasis: physiological conditions.
Olszewski WL
Lymphat Res Biol; 2003; 1(1):11-21; discussion 21-4. PubMed ID: 15624317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
